TrialClinical transplantation2021

Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study.

Yoshihiko Watarai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.